About Us

;

Who We Are

Vascular Dynamics, based in Mountain View, California, is a private medical device company developing catheter-delivered technologies to bring a better quality of life to patients who are resistant to conventional treatments for hypertension. The company’s implantable MobiusHD® System was awarded CE Mark certification in December 2015. In the United States, the company was one of the nine companies chosen in 2012 by the U.S. Food and Drug Administration (FDA) to participate in the Early Feasibility Study Investigational Device Exemption (IDE) Pilot Program for the company’s MobiusHD implant.

Vascular Dynamics is conducting clinical trials in the United States and Europe to evaluate the safety and performance of the MobiusHD device.

Management Team

Robert Stern

Robert Stern

President & CEO, Vascular Dynamics

Bob has served as president and CEO of Vascular Dynamics since November 2011. Prior to joining Vascular Dynamics he served as president and COO of Micrus Endovascular (MEND), which was acquired by Johnson & Johnson in 2010. Prior to Micrus, Bob served as president and CEO of Context Connect, a wireless technology company; as Executive VP and CFO of Qixel Capital Corporation, an internet holding company; and as VP and CFO of InnerDyne Inc. (IDYN), a surgical access and biotechnology company. Bob received a BS in Business Administration from the University of New Hampshire, Whittemore School of Business and Economics, and an M.B.A from the University of New Mexico, Anderson School of Management.

James McKinley

James McKinley

Chief Operating Officer

Jim brings years of experience in leadership roles at larger public medtech companies including Baxter, The Cooper Companies and Collagen Corporation, as well as an equal number of years in founding and leading medtech start-ups into and through the clinical stage. Companies in the latter group include Target Therapeutics, NuVasive, ReGen Biologics, EndoSphere and Advent Medical. He holds a graduate degree in business from the Darden School of Business at the University of Virginia and a B.S. in Economics from Johns Hopkins University.

Brent Seybold

Brent Seybold

Vice President, Technical Operations

Brent has extensive experience helping to transform medical devices from concepts to commercially viable products. He has served in senior technical roles at companies of various sizes including LuMend (Coronary/Peripheral CTO), Parallax Medical (Vertebroplasty), Genesis Medical Interventional (Coronary/ Peripheral Thrombectomy & Embolic Protection) and Micrus Endovascular (Ischemic Stroke). He joined the VDI team in 2011 and has been involved in R&D, Operations, clinical case support and physician training. Brent has a Bachelor of Science in Mechanical Engineering from the University of California, Davis.

Sujith Shetty

Sujith Shetty

Vice President, Clinical, Regulatory & Quality

Suji has served as vice president of Clinical, Regulatory, and Quality for Vascular Dynamics since March 2012. Prior to joining Vascular Dynamics he served as senior project manager, Clinical of Micrus Endovascular (MEND), which was acquired by Johnson and Johnson in 2010. Prior to Micrus, Suji was part of the clinical team at Pulmonx and Asthmatx, both companies with novel technology for lung conditions. Suji started his clinical research career as a research fellow at University of Southern California, where he participated in studies in Pulmonary and Critical Care and Cardiology. Suji received an M.B.B.S from Kempe Gowda Institute of Medical Science (Bangalore, India).

Board of Directors

Robert Stern

Robert Stern

Board Member, President & CEO, Vascular Dynamics

Bob has served as president and CEO of Vascular Dynamics since November 2011. Prior to joining Vascular Dynamics he served as president and COO of Micrus Endovascular (MEND), which was acquired by Johnson & Johnson in 2010. Prior to Micrus, Bob served as president and CEO of Context Connect, a wireless technology company; as Executive VP and CFO of Qixel Capital Corporation, an internet holding company; and as VP and CFO of InnerDyne Inc. (IDYN), a surgical access and biotechnology company. Bob received a BS in Business Administration from the University of New Hampshire, Whittemore School of Business and Economics, and an M.B.A from the University of New Mexico, Anderson School of Management.

Dr. Thomas Thaler

Dr. Thomas Thaler

Board Member, Investment Advisor HBM Partners AG

Dr. Thaler has more than 15 years of experience in investment management and financial research. He is a former senior equity analyst at Bank Julius Baer covering medical technology and healthcare service companies. He also has 15 years of experience in the biotech and medical technology industry holding senior management positions with Sulzer Medica, Schneider (Europe) and Boston Scientific. Dr. Thaler holds a MSc from the Swiss Federal Institute of Technology, (ETH) Zurich in Biochemistry, a PhD in life sciences and a Masters degree in Business Administration (ETH/BWI). Dr. Thaler is a board member of Vascular Dynamics, Ellipse Technologies, Interventional Spine, MiCardia, Tensys Medical and ValCare Medical.

Efi Cohen-Arazi

Efi Cohen-Arazi

Board Member, CEO Rainbow Medical

Mr. Cohen-Arazi has more than 25 years of experience in the medical and biotech industries involving executive management responsibility for both development manufacturing and business. Prior to co-founding Rainbow Medical, Mr. Cohen-Arazi served as CEO of IntecPharma, Israel, a company specializing in drug development and delivery. Previously, Mr. Cohen-Arazi was vice president of Corporate Manufacturing, Head of Contract Manufacturing and Site Head at U.S.-based Amgen Corporation. Mr. Cohen-Arazi held senior positions at Immunex in the U.S. and at the Merck-Serono Group in Switzerland. Mr. Cohen-Arazi holds advanced life sciences degrees from the Hebrew University of Jerusalem.

Ben Tsai

Ben Tsai

Board Member, Partner at Invus Opportunities

Mr. Tsai is currently a partner at Invus Opportunities. Previously, Mr. Tsai was a consultant of the Monitor Group. He holds an MBA degree from Harvard Business School and a BS degree in Business Administration from the University of Southern California.

Michael Henson

Michael Henson

Chairman

Mr. Henson has founded or served as CEO and chairman/board member for 18 emerging healthcare (medical device or biotechnology) firms. Seven of these were privately held firms acquired by multinational companies, while six have advanced through the initial public offering (IPO) stage. Ten of the firms founded by Mr. Henson have been acquired by major healthcare firms. Several of these companies remain closely held private firms. In total, these firms have received financial investments of approximately $1 billion and have employed in excess of 1,000 people. Mr. Henson also serves as a principal manager for four private investment funds and as an advisor to two additional private investment funds, all focused on early and mid – stage medical device startup ventures.

Are you a Healthcare Professional outside of the U.S.?

 

The following page contains content about Vascular Dynamics products, which are only available for healthcare professionals outside of the United States. This content is NOT intended for U.S. audiences. Do you wish to continue?

No Yes

Caution: In the United States, the MobiusHD® system is limited by law to investigational use only.

You have Successfully Subscribed!

Are you a Patient outside of the U.S.?

 

The following page contains content about Vascular Dynamics products, which are only available for patients outside of the United States. This content is NOT intended for U.S. audiences. Do you wish to continue?

No Yes

You have Successfully Subscribed!

Are you a Healthcare Professional in the U.S.?

 

The following page contains content about Vascular Dynamics products, which are only available for healthcare professionals in the United States. This content is ONLY intended for U.S. audiences. Do you wish to continue?

No Yes

Caution: In the United States, the MobiusHD® system is limited by law to investigational use only.

You have Successfully Subscribed!

Are you a Patient in the U.S.?

 

The following page contains content about Vascular Dynamics products, which are not available for marketing in the United States. This content is ONLY intended for U.S. audiences. Do you wish to continue?

No Yes

You have Successfully Subscribed!

Are you a Patient outside of the U.S.?

 

The following page contains content about Vascular Dynamics products, which are only available for patients outside of the United States. This content is NOT intended for U.S. audiences. Do you wish to continue?

No Yes

You have Successfully Subscribed!

Are you a Patient in the U.S.?

 

The following page contains content about Vascular Dynamics products, which are not available for marketing in the United States. This content is ONLY intended for U.S. audiences. Do you wish to continue?

No Yes

You have Successfully Subscribed!

Subscribe To Our Newsletter

Join our mailing list to receive the latest news and updates from our team.

You have Successfully Subscribed!

MobiusHD®Procedure

You have Successfully Subscribed!